- Bedoelde u
- argent
Zoekresultaten - 5 results
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
acid extraction and PCR inhibition are included in the assay. Clinical performance of OncoPredict HPV QT test was assessed as part of the “Validation of HPV Genotyping Tests” (VALGENT-2) framework, ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
ImmunoAssay (GP5 +/6+ EIA) using the VALGENT (VAL idation of HPV GEN otyping Tests) framework. METHODS: Clinical performance was assessed using 998 unselected, cervical screening samples enriched with 297 ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
efficiency and PCR inhibition. 1300 VALGENT-2 study samples (from women aged 20-60 attending the Scottish cervical cancer screening program) were tested with the index assay and the GP5 +/6+ PCR enzyme ...
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...